Efficacy and safety of TACE combined with anlotinib compared with TACE alone among patients with intermediate or advanced hepatocellular carcinoma (HCC): A randomized, controlled, phase II clinical study.

被引：0
|
作者：
Zeng, Hui
Shao, Guoliang
机构：
[1] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Inst Basic Med, Dept Intervent Radiol,Canc Hosp, Hangzhou, Peoples R China
[2] Zhejing Canc Hosp, Hangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
581
引用
收藏
页码：581 / 581
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of TACE combined with ablation and regorafenib for unresectable hepatocellular carcinoma: A real-world study.
    Xiong, Yiqi
    Gao, WenFeng
    Long, Jiang
    Hu, CaiXia
    Yuan, ChunWang
    Sun, Yu
    Shi, QinSheng
    Sun, Bin
    Zhang, YingHua
    Cui, XiongWei
    Hao, MeiJun
    Li, Jianjun
    Zhang, Yonghong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Analysis of the safety and effectiveness of TACE combined with targeted immunotherapy in the treatment of intermediate and advanced hepatocellular carcinoma
    Wenbin Liu
    Zhiguo Xie
    Kefeng Shen
    Lizhu Jiang
    Chongyan Liu
    Yongsheng Ge
    Jihai Yu
    Weidong Jia
    Jinliang Ma
    Hao Chen
    Medical Oncology, 40
  • [23] Analysis of the safety and effectiveness of TACE combined with targeted immunotherapy in the treatment of intermediate and advanced hepatocellular carcinoma
    Liu, Wenbin
    Xie, Zhiguo
    Shen, Kefeng
    Jiang, Lizhu
    Liu, Chongyan
    Ge, Yongsheng
    Yu, Jihai
    Jia, Weidong
    Ma, Jinliang
    Chen, Hao
    MEDICAL ONCOLOGY, 2023, 40 (09)
  • [24] EFFICACY AND SAFETY OF COMBINED SEQUENTIAL TREATMENT WITH RFA AND SORAFENIB IN PATIENTS WITH HCC IN INTERMEDIATE STAGE INELIGIBLE FOR TACE: A PROSPECTIVE RANDOMIZED OPEN STUDY
    de Stefano, G.
    Iodice, V.
    Signoriello, G.
    Scognamiglio, U.
    Farella, N.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S852 - S852
  • [25] Efficacy and safety of transarterial chemoembolization (TACE) in combination with tislelizumab and TKIs versus TACE for the treatment of Intermediate and advanced HCC: A retrospective cohort study
    Han, Y.
    Tang, S.
    Gao, Y.
    Yan, X.
    Zhi, W.
    Gong, T.
    ANNALS OF ONCOLOGY, 2024, 35 : S1494 - S1494
  • [26] Efficacy and safety of combined sequential treatment with radiofrequency ablation and sorafenib in patients with hepatocellular carcinoma in intermediate stage ineligible for tace: a prospective randomized open study
    de Stefano, G.
    Scognamiglio, U.
    Iodice, V.
    Farella, N.
    Simeone, E.
    Montesarchio, V.
    ANNALS OF ONCOLOGY, 2015, 26 : 103 - 104
  • [27] Efficacy and Safety of TACE Combined with Regorafenib versus TACE Combined with Camrelizumab in Hepatocellular Carcinoma With Untreatable Progression After TACE Combined with Sorafenib Therapy: A Case Control Study
    Ren, Yanqiao
    Liu, Yiming
    Song, Songlin
    Zheng, Chuansheng
    CANCER CONTROL, 2024, 31
  • [28] Treatment with camrelizumab plus tyrosine kinase inhibitors with or without TACE for intermediate-advanced hepatocellular carcinoma: a clinical efficacy and safety study
    Yin, Yaolin
    Li, Yonghe
    Xiong, Yongfu
    Xian, Yin
    Meng, Chun
    He, Kun
    He, Yi
    Li, Jingdong
    ONCOLOGIE, 2023, 25 (03) : 257 - 267
  • [29] Randomized, open label, multicenter, phase II trial of transcatheter arterial chemoembolization (TACE) therapy in combination with sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.
    Kudo, Masatoshi
    Ueshima, Kazuomi
    Torimura, Takuji
    Tanabe, Nobukazu
    Ikeda, Masafumi
    Aikata, Hiroshi
    Izumi, Namiki
    Yamasaki, Takahiro
    Nojiri, Shunsuke
    Hino, Keisuke
    Tsumura, Hidetaka
    Isoda, Norio
    Yasui, Kohichiroh
    Kuzuya, Teiji
    Okusaka, Takuji
    Furuse, Junji
    Kokudo, Norihiro
    Okita, Kiwamu
    Yoshimura, Kenichi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [30] Transarterial chemoembolization (TACE) combined with apatinib versus TACE combined with sorafenib in advanced hepatocellular carcinoma patients: a multicenter retrospective study
    Qiu, Zhiyu
    Shen, Lujun
    Jiang, Yiquan
    Qiu, Jiliang
    Xu, Zining
    Shi, Mengting
    Yu, Zhentao
    Ma, Yanping
    He, Wei
    Zheng, Yun
    Li, Binkui
    Wang, Guoying
    Yuan, Yunfei
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (04)
12345